Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danusertib in metastatic hormone refractory prostate cancer
NCT00766324Phase 2Completed
- Sponsor
- Nerviano Medical Sciences
- Start
- Sep 2007
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of danusertib in prostate cancer (PCa), sponsored by Nerviano Medical Sciences. Started Sep 2007; status: completed.
02
Drugs
danusertib
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00766324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00766324.